We reported that subsequent lower activation of DHA by SLC27A2, may result in less conversion of DHA to the DHA containing ethanolamide, providing a mechanism for the impaired synthesis of DHA-ethanolamide following LC n-3 PUFA intervention in obesity.13 Here, SLC27A2 is linked to obesity disorder.